Abstract: A method of labelling biological molecules with 18F, via attachment of fluorine to a metal complex, where the metal complex is conjugated to the biological molecule. The invention highlights the incorporation of hydrogen bonding (H-bonding) into the metal complex scaffold, and how this can be utilized to improve the kinetics of fluoride incorporation. Also provided are pharmaceutical compositions, kits and methods of in vivo imaging.

Abstract: The present invention relates to a method of labelling biological molecules with 18F, via attachment to fluorine to a macrocyclic metal complex of a non-radioactive metal, where the metal complex is conjugated to the biological molecule. Also provided are pharmaceutical compositions, kits and methods of in vivo imaging.

Abstract: A method of labelling biological molecules with 18F, via attachment of fluorine to a metal complex, where the metal complex is conjugated to the biological molecule. The invention highlights the incorporation of hydrogen bonding (H-bonding) into the metal complex scaffold, and how this can be utilised to improve the kinetics of fluoride incorporation. Also provided are pharmaceutical compositions, kits and methods of in vivo imaging.

Abstract: A method of labelling biological molecules with 18F, via attachment of fluorine to a metal complex, where the metal complex is conjugated to the biological molecule. The invention highlights the incorporation of hydrogen bonding (H-bonding) into the metal complex scaffold, and how this can be utilised to improve the kinetics of fluoride incorporation. Also provided are pharmaceutical compositions, kits and methods of in vivo imaging.

Abstract: A method of labelling biological molecules with 18F, via attachment of fluorine to a metal complex, where the metal complex is conjugated to the biological molecule. The invention highlights the incorporation of hydrogen bonding (H-bonding) into the metal complex scaffold, and how this can be utilised to improve the kinetics of fluoride incorporation. Also provided are pharmaceutical compositions, kits and methods of in vivo imaging.

Abstract: The present invention relates to a method of labelling biological molecules with 18F, via attachment to fluorine to a macrocyclic metal complex of a non-radioactive metal, where the metal complex is conjugated to the biological molecule. Also provided are pharmaceutical compositions, kits and methods of in vivo imaging.

Abstract: Compounds of formula I are useful in the separation of a gas such as oxygen, hydrogen, sulphur dioxide, alkenes and carbon monoxide from a fluid comprising the gas.Mn.sup.11 LX.sub.2 IIn formula I: L represents a monodentate ligand of formula IA and X is a species capable of existing as an anionPR.sup.1 R.sup.2 R.sup.3 IAwherein R.sup.1, R.sup.2 and R.sup.3 which may be identical or different represent substituted or unsubstituted alkyl, cycloalkyl or aryl groups or hydrogen and X represents --Cl, --Br, --I, --CN, --NO.sub.2, --NO.sub.3, --OH, --NCS or --NCO, provided that no more than two of the groups R.sup.1 R.sup.2 and R.sup.3 are substituted or unsubstituted aryl groups and that at least one of the groups R.sup.1, R.sup.2 and R.sup.3 is a substituted or unsubstituted alkyl, cycloalkyl or aryl group.

Abstract: Compounds of formula I are useful in the separation of a gas such as oxygen, hydrogen, sulphur dioxide, alkenes and carbon monoxide from a fluid comprising the gas.Mn.sup.II LX.sub.2 IIn formula I:L represents a monodentate ligand of formula IA and X is a species capable of existing as an anionPR.sup.1 R.sup.2 R.sup.3 Iawherein R.sup.1, R.sup.2 and R.sup.3 which may be identical or different represent substituted or unsubstituted alkyl, cycloalkyl or aryl groups or hydrogen and X represents --Cl, --Br, --I, --CN, --NO.sub.2, --NO.sub.3, --OH, --NCS or --NCO provided that no more than two of the groups R.sup.1, R.sup.2 and R.sup.3 are substituted or unsubstituted aryl groups and that at least one of the groups R.sup.1, R.sup.2 and R.sup.3 is a substituted or unsubstituted alkyl, cycloalkyl or aryl group.